tiprankstipranks
Sareum Holdings PLC (GB:SAR)
LSE:SAR
UK Market
SAR
Sareum Holdings
RESEARCH TOOLSreports

Sareum Holdings (SAR) Stock News & Sentiment

26 Followers
Sareum Restarts Key Toxicology Study as TYK2 Pipeline and Partnering Drive Half-Year Progress
Premium
Company Announcements
Sareum Restarts Key Toxicology Study as TYK2 Pipeline and Partnering Drive Half-Year Progress
1M ago
Sareum to Release Interim Results and Host Live Investor Presentation
Premium
Company Announcements
Sareum to Release Interim Results and Host Live Investor Presentation
1M ago
Sareum Restarts Phase 2-Enabling Toxicology Programme for Lead Autoimmune Drug SDC-1801
Premium
Company Announcements
Sareum Restarts Phase 2-Enabling Toxicology Programme for Lead Autoimmune Drug SDC-1801
2M ago
Sareum Holdings Passes All Resolutions at AGM, Strengthening Governance
Premium
Company Announcements
Sareum Holdings Passes All Resolutions at AGM, Strengthening Governance
4M ago
Sareum Holdings Advances Pipeline and Strengthens Portfolio
Premium
Company Announcements
Sareum Holdings Advances Pipeline and Strengthens Portfolio
4M ago
Sareum Holdings Announces AGM and Releases Annual Report
Premium
Company Announcements
Sareum Holdings Announces AGM and Releases Annual Report
5M ago
Sareum Holdings Enhances Financial Advisory Team with New Joint Broker Appointment
Premium
Company Announcements
Sareum Holdings Enhances Financial Advisory Team with New Joint Broker Appointment
5M ago
More GB:SAR News >

SAR News on the Web

Sareum Restarts Key Toxicology Study as TYK2 Pipeline and Partnering Drive Half-Year Progress
TipRanks News
Neutral
Sareum to Release Interim Results and Host Live Investor Presentation
TipRanks News
Bearish
Sareum Restarts Phase 2-Enabling Toxicology Programme for Lead Autoimmune Drug SDC-1801
TipRanks News
Neutral
Sareum reports progress across pipeline
ShareCast
Bullish
Sareum surges after confirming cash runway and progress on key drug candidate
Proactive Investors
Neutral
Sareum shares tumble after safety study halted
Proactive Investors
Neutral
Sareum starts toxicology studies for lead inhibitor
ShareCast
Neutral
Sareum shares rise 9% on progress with neurological and cancer therapies
Proactive Investors
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:SAR’s Media Buzz Sentiment?
Currently, no data Available
What is GB:SAR’s weekly average amount of articles?
Currently, no data Available
What is GB:SAR’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week